CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 0 percent. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $8.864 million which missed the analyst consensus estimate of $9.363 million by 5.33 percent. This is a 1.57 percent increase over sales of $8.727 million the same period last year.